Compare Dicks Sporting Goods Inc (DKS) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dicks Sporting Goods Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Dicks Sporting Goods Inc trades at $136.58 (market cap $13.26B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Dicks Sporting Goods Inc pays the higher dividend (3.71%). Which is the better fit depends on your goals — on Pluang, investors hold Dicks Sporting Goods Inc for 19 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| DKS | RPRX | |
|---|---|---|
Market Cap | $13.26B | $25.27B |
Volume | 2,292,035 | 3,671,183 |
Sector | Consumer Cyclical | Health |
52-Week High | $239.17 | $63.96 |
52-Week Low | $121.15 | $35.44 |
Typical Hold Time | 19 Days | 1 Days |
Enterprise Value | $20.31B | $32.50B |
Dividend Yield | 3.71% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DICK'S Sporting Goods (DKS) trades at $136.65, up 4.17% today, with a bearish technical signal but strong fundamentals including a P/E of 14.86 and ROE of 18.47%. Recent earnings show mixed results, with Q2 2026 missing estimates, while Q3 2026 results are pending. The company faces a securities class action lawsuit, with multiple law firms alerting investors of a November 2026 deadline, contributing to negative sentiment despite a dividend announcement of $1.25 payable in September 2026.
The outlook is cautious due to legal overhangs and a bearish technical trend, but valuation metrics remain attractive. Upside exists if the company exceeds Q3 earnings expectations and resolves legal issues. Key risks include the class action lawsuit, competitive pressures, and potential margin compression from increased investing activities. Analyst consensus is bullish with a $153.30 price target, suggesting 12% upside from current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dicks Sporting Goods Inc
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
